FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness

After many setbacks for genetic therapies, advisers to the Food and Drug Administration recommended approval of the first gene tr.....»»

Category: topSource: nprOct 12th, 2017

Price tag on gene therapy for rare form of blindness: $850,000

A first-of-its-kind genetic treatment for b.....»»

Category: topSource: latimesJan 3rd, 2018

The FDA just approved the first gene therapy to treat blindness (ONCE)

AP The US Food and Drug Administration just approved the first gene therapy for an inherited disease.  The treatment, called Luxturna, is for Leber congenital amaurosis, a hereditary form of blindness.  It's a one-time treatment is.....»»

Category: topSource: businessinsiderDec 19th, 2017

Gene therapy for rare form of blindness wins US approval

U.S. health officials have approved a breakthrough therapy that can improve the eyesight of patients with a rare form of inherited blindness......»»

Category: topSource: foxnewsDec 19th, 2017

Seeing hope: FDA panel considers gene therapy for blindness

Advisers to the U.S. Food and Drug Administration will meet Thursday to consider whether to recommend approval of a gene therapy aimed at improving vision for some people with hereditary blindness......»»

Category: topSource: foxnewsOct 9th, 2017

FDA Panel Votes to Support Leukemia Gene-Therapy Treatment

A group of cancer experts voted unanimously to support U.S. regulatory approval for a first-of-its kind gene therapy targeting an aggressive form of leukemia in children and young adults......»»

Category: smallbizSource: wsjJul 13th, 2017

The Latest: FDA panel endorses potential 1st US gene therapy

The Latest on a Food and Drug Administration panel's review of a gene therapy treatment (all times local): 3:30 p.m......»»

Category: topSource: foxnewsJul 12th, 2017

Medical Breakthrough Could Help the Blind See Using Genes from Algae

Gene therapy is the future of medicine, and curing blindness may be the first stop......»»

Category: topSource: newsweekJan 16th, 2018

Drugmakers see a pricing blueprint in an $850,000 gene therapy

SAN FRANCISCO (Reuters) - Global drugmakers are looking to a tiny biotech's $850,000 therapy for a rare type of blindness as a model for getting paid for highly expensive – and effective – new medicines......»»

Category: topSource: reutersJan 12th, 2018

Spark"s price for Luxturna blindness gene therapy too high: ICER

(Reuters) .....»»

Category: topSource: reutersJan 12th, 2018

Gene therapy for inherited blindness sets precedent with its $850,000 price tag

Such gene therapies present a pricing conundrum stemming from the fact that they're one-time treatments, unlike a course of pills or injections......»»

Category: topSource: washpostJan 3rd, 2018

Brainstorm Health: Health Industry Drivers, Spark Blindness Drug Price, ALS Gene Therapy


Category: europeSource: fortuneJan 3rd, 2018

Gene therapy for inherited blindness sets precedent: $850,000 price tag

Gene therapy for inherited blindness sets precedent: $850,000 price tag.....»»

Category: topSource: washpostJan 3rd, 2018

New Gene Therapy Switches Out Blindness Mutation

A new gene therapy targets a mutation that causes blindness and could restore vision in patients with a rare inherited condition......»»

Category: topSource: moneycentralDec 20th, 2017

FDA Blesses Blindness Treatment That Could Cost $1 Million

The Food and Drug Administration approved for sale the first therapy in the U.S. that delivers a functional gene to replace a faulty, disease-causing one......»»

Category: smallbizSource: wsjDec 20th, 2017

Gene Therapy for Blindness Approved by FDA in Groundbreaking Moment for DNA-Based Medicine

The price likely won't be announced until January, according to a spokesperson......»»

Category: topSource: newsweekDec 19th, 2017

Spark Therapeutics shares rise on FDA approval of new gene therapy for blindness

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchDec 19th, 2017

Nationwide Children"s gene therapy spinout raises $2.5M to test muscular dystrophy treatment

A gene therapy startup that spun out of Nationwide Children's Hospital six months ago has raised $2.5 million toward testing a treatment for a form of muscular dystrophy in patients. Myonexus Therapeutics Inc. is the fourth company to come out of ge.....»»

Category: topSource: bizjournalsDec 13th, 2017

New treatment for leukemia

Scientists at Stanford University have identified a molecule that can be targeted to cure leukemia, the most common form of cancer in childhood. The therapy is similar to but distinct from CD19-tar........»»

Category: topSource: thehindubusinesslineNov 21st, 2017

Gene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?

One price watchdog group says no. 2017 has been a marquee year for gene therapy and medical technolog.....»»

Category: europeSource: fortuneNov 16th, 2017

Spark: A Big Win for Gene Therapy. So Why Is It Falling?

Shares of Spark Therapeutics are down today, despite winning the recommendation of a FDA advisory panel for its experimental gene therapy......»»

Category: blogSource: barronsOct 13th, 2017